Asthma, COPD, Lung Cancer News | Treatment & Research Articles
The 2025 GOLD COPD report includes a new emphasis on CV disease and PH in COPD and major updates on spirometry, new COPD drugs, climate change, and more.
GOLD COPD Report 2025: Key Spirometry and Drug Updates
Nov 22, 2024 · The 2025 GOLD COPD report, titled “Global Strategy for Prevention, Diagnosis and Management of COPD: 2025 Report,” can now be downloaded from the GOLD website, along with a pocket guide to the report and the “2025 …
GINA 2024 Asthma Update: Revised Recommendations on …
Jun 28, 2024 · The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more.
Chronic Obstructive Pulmonary Disease (COPD) - Pulmonology …
Nov 15, 2023 · Overview. Chronic obstructive pulmonary disease (COPD) refers to a group of conditions that include emphysema and chronic bronchitis and is characterized by progressive airflow limitation and tissue destruction. 1 It is associated with structural changes in the lungs due to chronic inflammation, typically caused by prolonged exposure to noxious gasses or particles.
News And Features - Pulmonology Advisor
GOLD COPD 2025 Report: Key Spirometry and Drug Updates, New Emphasis on CVD, PH
Dupixent Approved as Add-On Maintenance Therapy in COPD
Oct 1, 2024 · The Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance therapy for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.. The approval was supported by data from the randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS (ClinicalTrials.gov Identifier ...
News Archive - Pulmonology Advisor
Dec 20, 2024 · Researchers compared COPD outcomes in patients who switched to triple therapy (LABA/LAMA/ICS) vs dual bronchodilators (LABA/LAMA) after using LABA/ICS.
Updated 2023 GOLD Report Revises COPD Definitions and …
Jan 20, 2023 · The 2023 report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) — “Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease” (COPD) 1 — details “an expanded range of therapies for COPD that now can be considered to improve mortality,” according to Gerard J. Criner, MD, FACP, FACCP, an author of the 2023 GOLD ...
Switching Between Inhalers, Both pMDI and DPI, Common in …
Oct 4, 2024 · Inhaler preference varied by age. In male and female patients aged 75 years and older, the use of pMDI was higher than use of DPI (in asthma: 18.9% vs 12.0%, P <.001; in COPD: 34.0% vs 25.7%, P <.001). In contrast, among male and female patients aged 40 to 60 years, the use of pMDI was lower than use of DPI (in asthma: 41.7% vs 48.7%, P <.001; in COPD: 41.0% vs 47.8%, P <.001).
Early Care by Pulmonologist Linked to Better Outcomes in Asthma …
Jun 11, 2024 · The cohort included 508 individuals identified as having undiagnosed COPD or asthma. Of those, 253 were randomly assigned to the intervention group (mean [SD] age, 63.4 [13.4] years; 64% male) and 255 to the usual-care group …